NFE2L2 and type 1 diabetes mellitus: In summary, we first demonstrated that UC alleviated pancreatic β-cell dysfunction in T1D, partially dependent on activating Nrf2 signaling to maintain glucose homeostasis, thus preventing the onset of T1D and slowing down its progression.